Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$306.88 - $380.0 $71,809 - $88,920
234 Added 4.58%
5,340 $2.02 Million
Q3 2023

Nov 03, 2023

SELL
$315.92 - $397.36 $5.57 Million - $7 Million
-17,627 Reduced 77.54%
5,106 $1.62 Million
Q2 2023

Aug 07, 2023

BUY
$346.15 - $392.09 $76,499 - $86,651
221 Added 0.98%
22,733 $8.72 Million
Q1 2023

May 01, 2023

SELL
$323.56 - $373.36 $11,648 - $13,440
-36 Reduced 0.16%
22,512 $8.41 Million
Q4 2022

Feb 03, 2023

SELL
$248.67 - $334.17 $240,215 - $322,808
-966 Reduced 4.11%
22,548 $7.45 Million
Q3 2022

Nov 03, 2022

BUY
$263.81 - $337.27 $968,446 - $1.24 Million
3,671 Added 18.5%
23,514 $6.21 Million
Q2 2022

Jul 27, 2022

SELL
$301.4 - $428.42 $181,744 - $258,337
-603 Reduced 2.95%
19,843 $6.21 Million
Q1 2022

Apr 26, 2022

BUY
$379.46 - $424.54 $44,396 - $49,671
117 Added 0.58%
20,446 $8.54 Million
Q4 2021

Jan 31, 2022

BUY
$373.53 - $434.12 $30,255 - $35,163
81 Added 0.4%
20,329 $8.52 Million
Q3 2021

Nov 09, 2021

BUY
$396.76 - $455.92 $140,453 - $161,395
354 Added 1.78%
20,248 $8.37 Million
Q2 2021

Jul 29, 2021

BUY
$372.36 - $412.07 $401,404 - $444,211
1,078 Added 5.73%
19,894 $7.88 Million
Q1 2021

May 04, 2021

BUY
$357.26 - $392.57 $4,287 - $4,710
12 Added 0.06%
18,816 $7.23 Million
Q2 2020

Jul 31, 2020

SELL
$270.93 - $320.3 $43,619 - $51,568
-161 Reduced 0.85%
18,804 $5.33 Million
Q1 2020

May 07, 2020

BUY
$243.44 - $359.98 $11,928 - $17,639
49 Added 0.26%
18,965 $5.23 Million
Q4 2019

Feb 11, 2020

SELL
$281.18 - $322.05 $2,530 - $2,898
-9 Reduced 0.05%
18,916 $6.08 Million
Q4 2019

Feb 04, 2020

BUY
$281.18 - $322.05 $5.32 Million - $6.09 Million
18,925 New
18,925 $6.06 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.